2023 - Research.com Medicine in Germany Leader Award
2012 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Internal Medicine and Dermatology
Michael Böhm mainly investigates Internal medicine, Cardiology, Endocrinology, Heart failure and Surgery. His study in Blood pressure, Endothelium, Myocardial infarction, Coronary artery disease and Renal sympathetic denervation falls under the purview of Internal medicine. His research in Blood pressure intersects with topics in Ambulatory, Denervation and Intensive care medicine.
He works in the field of Cardiology, namely Ejection fraction. His work deals with themes such as Sinus rhythm, Ivabradine, Heart rate and Quality of life, which intersect with Heart failure. His work on Catheter and Angiography as part of general Surgery study is frequently linked to In patient, therefore connecting diverse disciplines of science.
His primary areas of study are Internal medicine, Cardiology, Heart failure, Endocrinology and Blood pressure. He integrates Internal medicine with In patient in his study. His Cardiology research is multidisciplinary, incorporating perspectives in Ivabradine, Clinical trial and Surgery.
His Heart failure research integrates issues from Intensive care medicine, Placebo, Clinical endpoint, Hazard ratio and Heart disease. His works in Angiotensin II, Angiotensin II receptor type 1 and Renin–angiotensin system are all subjects of inquiry into Endocrinology. His Blood pressure research is multidisciplinary, relying on both Anesthesia and Kidney.
Michael Böhm mainly focuses on Internal medicine, Cardiology, Heart failure, Blood pressure and Denervation. Internal medicine and In patient are two areas of study in which Michael Böhm engages in interdisciplinary research. His work in Cardiology covers topics such as Stroke which are related to areas like Cardiovascular outcomes.
His biological study spans a wide range of topics, including Placebo, Ivabradine, Interquartile range and Intensive care medicine. Michael Böhm has included themes like Ambulatory and Kidney in his Blood pressure study. His Denervation research incorporates elements of Renal artery, Ambulatory blood pressure and Sympathectomy, Surgery, Catheter.
His scientific interests lie mostly in Internal medicine, Cardiology, Heart failure, Ejection fraction and Atrial fibrillation. Michael Böhm connects Internal medicine with In patient in his study. His work carried out in the field of Cardiology brings together such families of science as Stroke, Anesthesia and Blood pressure, Heart rate.
His research integrates issues of Placebo, Ivabradine, Randomized controlled trial and Intensive care medicine in his study of Heart failure. The various areas that he examines in his Ejection fraction study include Tolerability, Interquartile range and Heart transplantation. His Atrial fibrillation study incorporates themes from Cathepsin, Endocrinology and Bradykinin.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon.
European Heart Journal (2013)
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).
Kenneth Dickstein;Alain Cohen-Solal;Gerasimos Filippatos;John J V McMurray.
European Journal of Heart Failure (2008)
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial
Murray D. Esler;Henry Krum;Paul A. Sobotka;Markus P. Schlaich.
The Lancet (2010)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber.
The New England Journal of Medicine (2019)
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
Karl Swedberg;Michel Komajda;Michael Böhm;Jeffrey S Borer.
The Lancet (2010)
Circulating endothelial progenitor cells and cardiovascular outcomes.
Nikos Werner;Sonja Kosiol;Tobias Schiegl;Patrick Ahlers.
The New England Journal of Medicine (2005)
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)
Marcus D. Flather;Marcelo C. Shibata;Andrew J.S. Coats;Dirk J. Van Veldhuisen.
European Heart Journal (2005)
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
Holger Thiele;Uwe Zeymer;Franz-Josef Neumann;Miroslaw Ferenc.
The New England Journal of Medicine (2012)
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
Theresa A McDonagh;Marco Metra;Marianna Adamo;Roy S Gardner.
European Heart Journal (2021)
Rosuvastatin in Older Patients with Systolic Heart Failure
John Kjekshus;Eduard Apetrei;Vivencio Barrios;Michael Böhm.
The New England Journal of Medicine (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: